ReviewKorean circulation journal2019
Metabolic Syndrome in Adult Congenital Heart Disease.
Review in Korean circulation journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.
- Decreased lipid levels in adult with congenital heart disease: a systematic review and Meta-analysis.BMC cardiovascular disorders · 2023Pooled it
- CD36 as a Context-Dependent Regulator of Metabolic Switching in Acute and Chronic Hypoxia.Biomolecules · 2026Review
- Mapping the Biopsychosocial and Lifestyle Portrait of Adults With Congenital Heart Disease: A Comparative Study Across Sex and Age.CJC pediatric and congenital heart disease · 2026Article
- Apolipoprotein E E3/E4 genotype is associated with an increased risk of type 2 diabetes mellitus complicated with coronary artery disease.BMC cardiovascular disorders · 2024Article
- Prognosis of Chronic Kidney Disease and Metabolic Syndrome in Adults With Congenital Heart Disease.Journal of Korean medical science · 2023Article
- Cardiometabolic Risk Factors in Mexican Adults With Congenital Heart Disease.JACC. Advances · 2023Article
- Metabolic syndrome distribution based on diagnostic criteria and family history among adults in Al-Basra, Iraq.Journal of public health in Africa · 2023Article
- Environmental changes surrounding congenital heart disease.Clinical and experimental pediatrics · 2023Article
- Pathological implications of cellular stress in cardiovascular diseases.The international journal of biochemistry & cell biology · 2023Review
- Sexual Health Issue in Adult Congenital Heart Disease to Improve the Quality of Life.Korean circulation journal · 2022Article
- Early vascular aging in adult patients with congenital heart disease.Hypertension research : official journal of the Japanese Society of Hypertension · 2021Article
- American College of Cardiology Body Mass Index Counseling Quality Improvement Initiative.Pediatric cardiology · 2021Article
- Metabolic syndrome and coronary artery disease in adults with congenital heart disease.Cardiovascular diagnosis and therapy · 2021Review
- Adaptive Cardiac Metabolism Under Chronic Hypoxia: Mechanism and Clinical Implications.Frontiers in cell and developmental biology · 2021Review
- Factors That Influence Adherence to Medication in Adults With Congenital Heart Disease (ACHD).Frontiers in psychiatry · 2021Article
- Changes of hospitalization trend in the pediatric cardiology division of a single center by increasing adult with congenital heart disease.BMC cardiovascular disorders · 2020Article
- Mediterranean diet adherence in patients with congenital heart disease.American journal of cardiovascular disease · 2020Article
- Risk Stratification Models for Adults with Congenital Heart Disease.Korean circulation journal · 2019Article
- Public health implications of lifestyle and sociocultural determinants of stroke risk and serum biochemical markers among older adults in northern Thailand.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In adult congenital heart disease (ACHD), residua and sequellae after initial repair develop late complications such as cardiac failure, arrhythmias, thrombosis, aortopathy, pulmonary hypertension and others. Acquired lesions with aging such as hypertension, diabetes mellitus, obesity can be negative influence on original cardiovascular disease (CVD). Also, atherosclerosis may pose an additional health problem to ACHD when they grow older and reach the age at which atherosclerosis becomes clinically relevant. In spite of the theoretical risk of atherosclerosis in ACHD due to above mentioned factors, cyanotic ACHDs even after repair are noted to have minimal incidence of coronary artery disease (CAD). Acyanotic ACHD has similar prevalence of CAD as the general population. However, even in cyanotic ACHD, CAD can develop when they have several risk factors for CAD. The prevalence of risk factor is similar between ACHD and the general population. Risk of premature atherosclerotic CVD in ACHD is based, 3 principal mechanisms: lesions with coronary artery abnormalities, obstructive lesions of left ventricle and aorta such as coarctation of the aorta and aortopathy. Coronary artery abnormalities are directly affected or altered surgically, such as arterial switch in transposition patients, may confer greater risk for premature atherosclerotic CAD. Metabolic syndrome is more common among ACHD than in the general population, and possibly increases the incidence of atherosclerotic CAD even in ACHD in future. Thus, ACHD should be screened for metabolic syndrome and eliminating risk factors for atherosclerotic CAD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.